Pfizer
PFE
$25.39
Share price
-0.12%
Change (1 day)
-37.39%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
Pfizer (PFE) - Total assets
Total assets on the balance sheet as of December 2023 : $226.50 B
According to Pfizer's latest financial reports the company's total assets are $226.50 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Pfizer - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $226.50 B | 14.86% |
| 2022-12-31 | $197.20 B | 8.67% |
| 2021-12-31 | $181.47 B | 17.67% |
| 2020-12-31 | $154.22 B | -7.97% |
| 2019-12-31 | $167.59 B | 5.13% |
| 2018-12-31 | $159.42 B | -7.2% |
| 2017-12-31 | $171.79 B | 0.11% |
| 2016-12-31 | $171.61 B | 2.53% |
| 2015-12-31 | $167.38 B | -0.11% |
| 2014-12-31 | $167.56 B | -2.64% |
| 2013-12-31 | $172.10 B | -7.37% |
| 2012-12-31 | $185.79 B | -1.17% |
| 2011-12-31 | $188.00 B | -3.6% |
| 2010-12-31 | $195.01 B | -8.42% |
| 2009-12-31 | $212.94 B | 91.59% |
| 2008-12-31 | $111.14 B | -3.57% |
| 2007-12-31 | $115.26 B | -0.24% |
| 2006-12-31 | $115.54 B | -1.22% |
| 2005-12-31 | $116.97 B | -4.96% |
| 2004-12-31 | $123.07 B | 5.4% |
| 2003-12-31 | $116.77 B | 151.91% |
| 2002-12-31 | $46.35 B | 18.4% |
| 2001-12-31 | $39.15 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | -26.02% | 🇺🇸 USA |
 Novartis NVS | $99.94 B | -55.87% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $73.21 B | -67.68% | 🇺🇸 USA |
 Eli Lilly LLY | $64.00 B | -71.74% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | -57.11% | 🇺🇸 USA |
 Merck MRK | $106.67 B | -52.90% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $95.15 B | -57.99% | 🇺🇸 USA |
 AstraZeneca AZN | $101.11 B | -55.36% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $75.11 B | -66.84% | 🇬🇧 UK |